Dr. Fatih M Uckun, M.D., Ph.D, is a member of American Society for Clinical Investigation (ASCI), an honor society for physician-scientists, and an active member of several professional organizations, including ASH, ASCO and AACR. He earned his doctoral degrees at University of Heidelberg and completed his residency training in Pediatrics, fellowship training in Hematology/Oncology/Blood and Bone marrow stem cell transplantation, as well as postdoctoral research training in Immunology at the University of Minnesota. Currently, he is the Professor in the Department of Pediatrics, Keck School of Medicine, University of Southern California. He is the Head of Translational Research in Leukemia and Lymphoma at the Children’s Center for Cancer and Blood diseases/Children’s Hospital Los Angeles and a member of the translational Oncology program at the USC Norris Comprehensive Cancer Center. He directs an NHI/NCI- funded Nanomedicine R&D program at the Children’s Hospital Los Angeles. He serves as the Chair of the Biotargeting Working Group of the NCI Alliance for Nonotechnology in Cancer. He has more than 20 years of professional experience in developmental therapeutics and biopharmaceuticals. He has published more than 450 peer-reviewed papers and he has authored numerous review articles and book chapters. He received numerous awards including the Stohlman Memorial Award of the Leukemia Society of America. He is the Editor-in Chief of the Journal of Nanomedicine and Nanotechnology and has served as a member of several editorial boards and NIH grant review/special emphasis panels.
Immunity and HIV infections; Microbibides; Rational design of several anti-HIV agents, including the epigenetic inhibitor of HIV replication, Stampidine, which has entered clinical testing.